trade name: Arimidex®) is a drug indicated switching from tamoxifen to arimidex the off-label use of reducing estrogens (in particular and more importantly, estradiol) in men. Excess estradiol in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism. switching from tamoxifen to arimidex athletes and body builders will also use anastrozole as use.

Wikipedia, the free encyclopedia(Redirected from Arimidex)Jump to: navigation, searchAnastrozoleSystematic switching from tamoxifen to arimidex name2-[3-(1-cyano-1-methyl-ethyl)- 5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]- 2-methyl- propanenitrileIdentifiersCAS number 120511-73-1ATC code L02BG03PubChem 2187DrugBank APRD00016Chemical dataFormula C17H19N5Mol. mass 293.366 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability 83-85%Protein binding 40%Metabolism 85% hepaticHalf life 72 hoursExcretion 11% renalTherapeutic considerationsPregnancy cat. ?Legal status Rx only (U.S.)Routes oralAnastrozole (INN, trade name: Arimidex®) is a drug indicated in the off-label use of reducing estrogens (in switching from tamoxifen to arimidex and more importantly, estradiol) in men. Excess switching from tamoxifen to arimidex in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism. Some athletes and body builders will also use anastrozole as a part of their switching from tamoxifen to arimidex cycle switching from tamoxifen to arimidex reduce and prevent switching from tamoxifen to arimidex of excess estrogens; in particular, gynecomastia.

the growth disorder is through hormones which switching from tamoxifen to arimidex trigger the early onset of puberty. The treatment puberty.